It also reviews the much more promisingIL-12-based techniques in animal models.345 Moreover, IL-12 has been demonstrated to be highly efficient inanimal models of tumor treatment due to its ability to promote variousdirect and indirect anticancer actions related to innate immunity,adaptive immunity, and nonimmune pathways. The gene discussed is SPRR2A; the disease is neoplasm.